CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.330

+17.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom r. phillips who wrote (243)	2/15/2000 10:18:00 PM
From: wolfdog2	Read Replies (2) of 668

Tom, I agree with Tom that genomics is a wild card here. The biotechs as of late have been acting like dot coms, so enjoy the ride. Placing a value on the company isn't easy. You need to line up all the late phase clinical trials, make an assessment of the likelihood of success and then try to estimate annual sales going out. No question there's a synergy here. Many more drugs in the pipeline, it removes the risk that a failure could knock the company and the stock into the trash can. As a larger company, analyst interest interest will no doubt increase, which in turn will increase the value of the stock.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next